COMMUNIQUÉS West-GlobeNewswire

NKGen Biotech Receives Notification From Nasdaq Related to Delayed Quarterly Report

22/08/2024 - 22:40

SANTA ANA, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), today announced it received a standard notice (the “Notice”) on August 20, 2024 from the Listing [...]

Ovarian Cancer Canada announces its annual Walk of Hope to support Canadians facing ovarian cancer

22/08/2024 - 22:37

Join or donate to one of the 31 walks across Canada on September 8, visit www.ovariancancerwalkofhope.ca TORONTO, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Held annually during Ovarian Cancer Awareness Month in September, [...]

Vision Sensing Acquisition Corp. Announces Letter of Intent with Convergence CT, Inc.

22/08/2024 - 22:35

Agrees to Terminate Previous Agreement with Mediforum Co., Ltd. Convergence CT, Inc. (“CCT”) is a provider of technologies to manage big data for the benefit of patients, communities, providers, and researchers, and [...]

SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024

22/08/2024 - 22:30

SANTA CLARA, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the [...]

Kane Biotech to Release Second Quarter 2024 Financial Results on August 29, 2024 – Conference Call to Follow

22/08/2024 - 22:30

WINNIPEG, Manitoba, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”) will announce its second quarter 2024 financial results after market close on Thursday, August 29, 2024 [...]

Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

22/08/2024 - 22:30

DEER PARK, Ill., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare [...]

Travere Therapeutics to Present Abstracts at the Society for the Study of Inborn Errors of Metabolism Annual Symposium 2024

22/08/2024 - 22:30

Posters to be presented highlight clinical study designs investigating pegtibatinase as the first potential disease-modifying treatment for classical homocystinuria SAN DIEGO, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Travere [...]

Treace Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference

22/08/2024 - 22:15

PONTE VEDRA, Fla., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]

BrightSpring Health Services, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

22/08/2024 - 22:05

LOUISVILLE, Ky., Aug. 22, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that the Company will participate in the Morgan Stanley 22 nd Annual [...]

Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

22/08/2024 - 22:05

REDWOOD CITY, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be [...]

NeuroPace to Participate in Upcoming Healthcare Conferences in September

22/08/2024 - 22:05

MOUNTAIN VIEW, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will participate in [...]

RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences

22/08/2024 - 22:05

ALISO VIEJO, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, [...]

Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

22/08/2024 - 22:03

SEATTLE, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical [...]

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

22/08/2024 - 22:00

Company announcement – No. 41 / 2024 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark, August 22, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR [...]

CORRECTION -- InnovAge PACE Celebrates Anniversary of Vibrant Sacramento Center

22/08/2024 - 21:20

PACE Program Provides Highly Coordinated Personalized Senior Care in Partnership with Eskaton and Adventist Health In a release issued under the same headline on Friday, August 16, 2024, by InnovAge, please note the [...]

Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine

22/08/2024 - 20:15

The updated COVID-19 vaccine is tailored to the KP.2 strain of the SARS-CoV-2 Omicron JN.1 lineage and is recommended for individuals 6 months of age and older The KP.2 adaptation is based on FDA guidance, which stated [...]

Six-month interim report (Q2) 2024

22/08/2024 - 17:49

Company release No. 16/2024 ALK delivers 21% organic revenue growth with an operating profit margin of 19% in Q2 (unaudited) Revenue growth was driven by a continued strong momentum in tablet sales, and improved [...]

ALK upgrades its full-year revenue and earnings outlook

22/08/2024 - 17:38

ALK ( ALKB:DC / OMX: ALK B / AKBLF ) today announced that the full-year financial outlook has been upgraded to reflect the current performance and outlook for the remainder of the year. Revenue is now expected to grow [...]

ProLynx annonce des résultats précliniques pour le sémaglutide à action prolongée nécessitant une administration mensuelle

22/08/2024 - 17:27

SAN FRANCISCO, 22 août 2024 (GLOBE NEWSWIRE) -- ProLynx Inc. a annoncé aujourd'hui que sa technologie avait permis de créer un sémaglutide à action prolongée pouvant être administré une fois par mois. La technologie de [...]